Kimberley R. Doucette, MD, MSC; and David H. Vesole, MD, PhD, discuss updates to frontline treatment in multiple myeloma.
Kimberley R. Doucette, MD, MSC
Advertisement
Articles by Kimberley R. Doucette, MD, MSC
Advertisement
Latest Updated Articles
Recent Advancements and Future Directions in Frontline Treatment of Multiple MyelomaPublished: July 15th 2022 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
2
FDA Approves Revumenib in R/R NPM1-Mutant AML
3
Awareness Fuels Progress: Upcoming Advances in Breast Cancer Treatment
4
FDA Approves Belantamab Mafodotin in R/R Multiple Myeloma
5
